Risk factor
Good trading liquidity
Profitability factor
Greatly overvalued vs peers
About
Sartorius Stedim Biotech S.A. produces and sells instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products....
Company Valuation
Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers. In particular, the stock is overpriced on P/E, 'expensive' on EV/EB
Target Price
The average target price of DIM.PA is 229 and suggests 14% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendation
Buy
Sell